Legend Biotech Corporation
LEGN
$34.86
$1.374.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -54.30M | -30.82M | -39.69M | -125.38M | -101.00M |
| Total Depreciation and Amortization | 15.60M | 11.97M | 5.88M | 5.85M | 5.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.90M | 37.77M | 15.41M | 142.08M | 66.30M |
| Change in Net Operating Assets | -75.30M | -31.13M | 47.21M | -35.59M | -74.00M |
| Cash from Operations | -85.10M | -12.21M | 28.80M | -13.04M | -103.60M |
| Capital Expenditure | -7.50M | -12.37M | -5.01M | -9.22M | -2.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -160.50M | 650.86M | -15.00M | -156.30M | 258.60M |
| Cash from Investing | -168.00M | 638.49M | -20.00M | -165.53M | 256.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.30M | -958.00K | -602.00K | -1.26M | -800.00K |
| Issuance of Common Stock | 100.00K | 311.00K | 1.27M | 273.00K | 1.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.20M | -647.00K | 670.00K | -990.00K | 600.00K |
| Foreign Exchange rate Adjustments | -1.20M | -2.58M | 2.84M | 4.44M | 1.40M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -255.50M | 623.06M | 12.31M | -175.12M | 155.00M |